For months and even years, medical-device innovator NeuroMetrix (NASDAQ:NURO) stayed largely under financial traders’ radars. In 2021, however, plenty of investors are aware of NURO stock. Source: ...

Support.com and NeuroMetrix climb in a retail investor-fueled rally. Support.com, which provides cloud-based software and services, was up nearly 60% to $31.20, while the biopharma NeuroMetrix climbed ...

NeuroMetrix (NASDAQ:NURO) stock fell ~4% on July 21 after the company reported a decline in Q2 revenue and a widened net loss. YTD, the stock has shed over -28%. See chart here. Revenues fell -3.4% ...

WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm on ...

If not now, when? It’s a question would-be NeuroMetrix (NASDAQ:NURO) investors might be asking themselves. More aptly and as it relates to the performance of NURO stock, if not then, then or then, ...

Neurometrix Inc. (NASDAQ:NURO) shares flew higher Tuesday and Wednesday on continued momentum after the company announced its Quell device received Breakthrough Designation from the FDA for treating ...

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NAS: NURO) (the "Company" or "NURO"), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes ...

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NAS: NURO) , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced the ...